Financials data is unavailable for this security.
View more
Year on year Prim SA grew revenues 9.77% from 197.25m to 216.51m while net income improved 51.02% from 8.39m to 12.67m.
| Gross margin | 38.28% |
|---|---|
| Net profit margin | 5.02% |
| Operating margin | 6.44% |
| Return on assets | 5.73% |
|---|---|
| Return on equity | 9.14% |
| Return on investment | 8.34% |
More ▼
Cash flow in EURView more
In 2023, cash reserves at Prim SA fell by 4.44m. Cash Flow from Financing totalled 30.37m or 14.03% of revenues. In addition the company used 31.25m for operations while cash used for investing totalled 3.67m.
| Cash flow per share | 1.31 |
|---|---|
| Price/Cash flow per share | 7.43 |
| Book value per share | 7.46 |
|---|---|
| Tangible book value per share | 6.12 |
More ▼
Balance sheet in EURView more
| Current ratio | 2.23 |
|---|---|
| Quick ratio | 1.13 |
| Total debt/total equity | 0.1507 |
|---|---|
| Total debt/total capital | 0.131 |
More ▼
Growth rates in EUR
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 21.84% and 51.46%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked the highest relative to its industry peers.
| Div yield(5 year avg) | 3.44% |
|---|---|
| Div growth rate (5 year) | -5.01% |
| Payout ratio (TTM) | 50.16% |
| EPS growth(5 years) | -1.78 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 19.12 |
More ▼
